The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II open-label, single-center, nonrandomized trial of Y90-radioembolization in combination with nivolumab in Asian patients with advanced hepatocellular carcinoma: CA 209-678.
 
Wai Meng David Tai
Honoraria - Bayer
Consulting or Advisory Role - Bayer; Ipsen; MSD; Novartis Pharmaceuticals UK Ltd.
Speakers' Bureau - Eisai; Novartis
Research Funding - Bristol-Myers Squibb; Novartis; Sirtex Medical
 
Kelvin Siu Hoong Loke
Speakers' Bureau - Sirtex Medical
 
Apoorva Gogna
No Relationships to Disclose
 
Sze Huey Tan
No Relationships to Disclose
 
David Chee Eng Ng
No Relationships to Disclose
 
Tiffany Priyanthi Hennedige
No Relationships to Disclose
 
Farah Irani
No Relationships to Disclose
 
Joycelyn Jie Xin Lee
Consulting or Advisory Role - Bayer; Ipsen
 
Chow Wei Too
No Relationships to Disclose
 
Matthew C.H. Ng
Honoraria - ASLAN Pharmaceuticals; Lilly; MSD Oncology; Taiho Pharmaceutical
Consulting or Advisory Role - Bristol-Myers Squibb; MSD Oncology; MSD Oncology
Speakers' Bureau - Lilly
Research Funding - ASLAN Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD Oncology; Taiho Pharmaceutical
 
Chee Kian Tham
No Relationships to Disclose
 
Justina Yick Ching Lam
No Relationships to Disclose
 
Si-Lin Koo
No Relationships to Disclose
 
Alexander Chung
No Relationships to Disclose
 
Han Chong Toh
Employment - Tessa Therapeutics; Tessa Therapeutics
Leadership - Tessa Therapeutics
Stock and Other Ownership Interests - Tessa Therapeutics
Honoraria - Roche/Genentech; Roche/Genentech
Consulting or Advisory Role - Biosceptre International
Speakers' Bureau - Merck Sharp & Dohme
Research Funding - Tessa Therapeutics
Patents, Royalties, Other Intellectual Property - IP related to cancer immunotherapy for Tessa Therapeutics Ltd
Travel, Accommodations, Expenses - Tessa Therapeutics
 
Choon Hua Thng
No Relationships to Disclose
 
Kiat Hon Lim
No Relationships to Disclose
 
Joe Poh Sheng Yeong
No Relationships to Disclose
 
Chung Yip Chan
No Relationships to Disclose
 
Su Pin Choo
Honoraria - Bayer Health; Bristol-Myers Squibb; Celgene; Eisai; Ipsen
Consulting or Advisory Role - Bayer Health; Bristol-Myers Squibb; Celgene; Eisai; Ipsen
Speakers' Bureau - Bristol-Myers Squibb